![Osamu Nureki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Osamu Nureki
Direktor/Vorstandsmitglied bei
Curreio, Inc.
Vermögen: 281 139 $ am 31.10.2026
Profil
Osamu Nureki is the founder of Modalis Therapeutics Corp., which was founded in 2016.
He holds the title of Outside Director at the company.
He is currently working as an Outside Director at Curreio, Inc. since 2019 and as a Professor at the University of Tokyo since 2008.
Dr. Nureki completed his undergraduate and graduate degrees at the University of Tokyo.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2025 | 1 581 300 ( 1,39 % ) | 281 139 $ | 31.10.2026 |
Aktive Positionen von Osamu Nureki
| Unternehmen | Position | Beginn |
|---|---|---|
Curreio, Inc.
 Curreio, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services | Direktor/Vorstandsmitglied | 01.11.2019 |
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.04.2008 |
Ehemalige bekannte Positionen von Osamu Nureki
| Unternehmen | Position | Ende |
|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Gründer | - |
Ausbildung von Osamu Nureki
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
University of Tokyo
University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Modalis Therapeutics Corp.
 Modalis Therapeutics Corp. BiotechnologyHealth Technology Develops transformative therapeutics for diseases which are caused by malfunctioning of genes | Health Technology |
Curreio, Inc.
Curreio, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services | Health Technology |
